VXRT

Vaxart, Inc. is a clinical-stage biotechnology firm based in South San Francisco, California, focused on revolutionizing vaccination through its proprietary oral recombinant protein vaccine platform. The company is developing innovative oral vaccines to target significant unmet medical needs, with an emphasis on viral infections and gastrointestinal diseases, thereby enhancing immunization strategies and patient compliance. Vaxart's strong commitment to research and development positions it as a potential leader in the vaccine arena, dedicated to addressing critical public health challenges with its novel approaches.